Spike recognition and neutralization of SARS-CoV-2 Omicron subvariants elicited after the third dose of mRNA vaccine

被引:22
作者
Tauzin, Alexandra [1 ,2 ]
Nicolas, Alexandre [1 ,2 ]
Ding, Shilei [1 ]
Benlarbi, Mehdi [1 ,2 ]
Medjahed, Halima [1 ]
Chatterjee, Debashree [1 ]
Dionne, Katrina [1 ,2 ]
Gong, Shang Yu [1 ,3 ]
Gendron-Lepage, Gabrielle [1 ]
Bo, Yuxia [1 ,4 ]
Perreault, Josee [5 ]
Goyette, Guillaume [1 ]
Gokool, Laurie [1 ]
Arlotto, Pascale [1 ]
Morrisseau, Chantal [1 ]
Tremblay, Cecile [1 ,2 ]
Martel-Laferriere, Valeri [1 ,2 ,3 ,4 ,5 ,6 ,7 ]
De Serres, Gaston [6 ]
Levade, Ines [7 ]
Kaufmann, Daniel E. [1 ,8 ,9 ,10 ]
Cote, Marceline [4 ]
Bazin, Renee [5 ]
Finzi, Andres [1 ,2 ,3 ]
机构
[1] Ctr Rech CHUM, Montreal, PQ H2X 0A9, Canada
[2] Univ Montreal, Dept Microbiol Infectiol & Immunol, Montreal, PQ H2X 0A9, Canada
[3] McGill Univ, Dept Microbiol & Immunol, Montreal, PQ H3A 2B4, Canada
[4] Univ Ottawa, Ctr Infect, Dept Biochem, Microbiol & Immunol, Ottawa, ON K1H 8M5, Canada
[5] Hema Quebec Affaires Med & Innovat, Quebec City, PQ G1V 5C3, Canada
[6] Inst Natl Sante Publ Quebec, Quebec City, PQ H2P 1E2, Canada
[7] Inst Natl St Publ Quebec, Lab St Publ Quebec, Sainte Anne De Bellevue, PQ H9X 3R5, Canada
[8] Univ Montreal, Dept Medecine, Montreal, PQ H3T 1J4, Canada
[9] Univ Hosp Lausanne, Dept Med, Div Infect Dis, CH-1011 Lausanne, Switzerland
[10] Univ Lausanne, CH-1011 Lausanne, Switzerland
基金
芬兰科学院; 加拿大创新基金会;
关键词
B cell responses; coronavirus; COVID-19; CP: Immunology; humoral responses; hybrid immunity; neutralization; Omicron subvariants; SARS-CoV-2; spike glycoproteins; third mRNA vaccine dose;
D O I
10.1016/j.celrep.2023.111998
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Several severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron subvariants have recently emerged, becoming the dominant circulating strains in many countries. These variants contain a large num-ber of mutations in their spike glycoprotein, raising concerns about vaccine efficacy. In this study, we eval-uate the ability of plasma from a cohort of individuals that received three doses of mRNA vaccine to recognize and neutralize these Omicron subvariant spikes. We observed that BA.4/5 and BQ.1.1 spikes are markedly less recognized and neutralized compared with the D614G and other Omicron subvariant spikes tested. Also, individuals who have been infected before or after vaccination present better humoral responses than SARS-CoV-2-naive vaccinated individuals, thus indicating that hybrid immunity generates better hu-moral responses against these subvariants.
引用
收藏
页数:15
相关论文
共 50 条
[11]  
Garrett N, 2022, medRxiv, DOI [10.1101/2021.12.20.21268130, 10.1101/2021.12.20.21268130, DOI 10.1101/2021.12.20.21268130, https://doi.org/10.1101/2021.12.20.21268130]
[12]   Distinct antibody and memory B cell responses in SARS-CoV-2 naive and recovered individuals after mRNA vaccination [J].
Goel, Rishi R. ;
Apostolidis, Sokratis A. ;
Painter, Mark M. ;
Mathew, Divij ;
Pattekar, Ajinkya ;
Kuthuru, Oliva ;
Gouma, Sigrid ;
Hicks, Philip ;
Meng, Wenzhao ;
Rosenfeld, Aaron M. ;
Dysinger, Sarah ;
Lundgreen, Kendall A. ;
Kuri-Cervantes, Leticia ;
Adamski, Sharon ;
Hicks, Amanda ;
Korte, Scott ;
Oldridge, Derek A. ;
Baxter, Amy E. ;
Giles, Josephine R. ;
Weirick, Madison E. ;
McAllister, Christopher M. ;
Dougherty, Jeanette ;
Long, Sherea ;
D'Andrea, Kurt ;
Hamilton, Jacob T. ;
Betts, Michael R. ;
Prak, Eline T. Luning ;
Bates, Paul ;
Hensley, Scott E. ;
Greenplate, Allison R. ;
Wherry, E. John .
SCIENCE IMMUNOLOGY, 2021, 6 (58) :1-19
[13]   Contribution of single mutations to selected SARS-CoV-2 emerging variants spike antigenicity [J].
Gong, Shang Yu ;
Chatterjee, Debashree ;
Richard, Jonathan ;
Prevost, Jeremie ;
Tauzin, Alexandra ;
Gasser, Romain ;
Bo, Yuxia ;
Vezina, Dani ;
Goyette, Guillaume ;
Gendron-Lepage, Gabrielle ;
Medjahed, Halima ;
Roger, Michel ;
Cote, Marceline ;
Finzi, Andres .
VIROLOGY, 2021, 563 :134-145
[14]   mRNA booster immunization elicits potent neutralizing serum activity against the SARS-CoV-2 Omicron variant [J].
Gruell, Henning ;
Vanshylla, Kanika ;
Tober-Lau, Pinkus ;
Hillus, David ;
Schommers, Philipp ;
Lehmann, Clara ;
Kurth, Florian ;
Sander, Leif E. ;
Klein, Florian .
NATURE MEDICINE, 2022, 28 (03) :477-+
[15]  
IDSA, 2022, SARS COV 2 VAR
[16]   Isolation and characterization of cross-neutralizing coronavirus antibodies from COVID-19+subjects [J].
Jennewein, Madeleine F. ;
MacCamy, Anna J. ;
Akins, Nicholas R. ;
Feng, Junli ;
Homad, Leah J. ;
Hurlburt, Nicholas K. ;
Seydoux, Emily ;
Wan, Yu-Hsin ;
Stuart, Andrew B. ;
Edara, Venkata Viswanadh ;
Floyd, Katharine ;
Vanderheiden, Abigail ;
Mascola, John R. ;
Doria-Rose, Nicole ;
Wang, Lingshu ;
Yang, Eun Sung ;
Chu, Helen Y. ;
Torres, Jonathan L. ;
Ozorowski, Gabriel ;
Ward, Andrew B. ;
Whaley, Rachael E. ;
Cohen, Kristen W. ;
Pancera, Marie ;
McElrath, M. Juliana ;
Englund, Janet A. ;
Finzi, Andres ;
Suthar, Mehul S. ;
McGuire, Andrew T. ;
Stamatatos, Leonidas .
CELL REPORTS, 2021, 36 (02)
[17]   Ad26.COV2.S breakthrough infections induce high titers of neutralizing antibodies against Omicron and other SARS-CoV-2 variants of concern [J].
Kitchin, Dale ;
Richardson, Simone, I ;
van der Mescht, Mieke A. ;
Motlou, Thopisang ;
Mzindle, Nonkululeko ;
Moyo-Gwete, Thandeka ;
Makhado, Zanele ;
Ayres, Frances ;
Manamela, Nelia P. ;
Spencer, Holly ;
Lambson, Bronwen ;
Oosthuysen, Brent ;
Kaldine, Haajira ;
du Pisanie, Marizane ;
Mennen, Mathilda ;
Skelem, Sango ;
Williams, Noleen ;
Ntusi, Ntobeko A. B. ;
Burgers, Wendy A. ;
Gray, Glenda G. ;
Bekker, Linda-Gail ;
Boswell, Michael T. ;
Rossouw, Theresa M. ;
Ueckermann, Veronica ;
Moore, Penny L. .
CELL REPORTS MEDICINE, 2022, 3 (03)
[18]  
Kurhade C., 2022, bioRxiv
[19]   Neutralization of Omicron BA.1, BA.2, and BA.3 SARS-CoV-2 by 3 doses of BNT162b2 vaccine [J].
Kurhade, Chaitanya ;
Zou, Jing ;
Xia, Hongjie ;
Cai, Hui ;
Yang, Qi ;
Cutler, Mark ;
Cooper, David ;
Muik, Alexander ;
Jansen, Kathrin U. ;
Xie, Xuping ;
Swanson, Kena A. ;
Shi, Pei-Yong .
NATURE COMMUNICATIONS, 2022, 13 (01)
[20]  
Li WW, 2022, CELL REP, V38, DOI [10.1016/j.celrep.2021.110210, 10.1101/2021.08.02.454546]